News
Onco360®, the nation’s leading independent specialty pharmacy, has been selected as a pharmacy partner by Deciphera ...
4d
MedPage Today on MSNBTK Inhibitors for Multiple SclerosisMultiple sclerosis (MS) includes both peripheral and central nervous system (CNS) inflammation, and an anti-inflammatory ...
GlobalData on MSN17h
Enrolment concludes in Phase III trial of Dizal’s sunvozertinib for NSCLCThe trial is being carried out in 16 nations and regions, including Asia, North America, Europe, and South America.
Discover which therapies are expected to grab the HER2-low cancers market share @ HER2-low Cancers Market Report The HER2-low ...
While fever is typically a sign of infection, a persistent, unexplained fever without any identifiable cause could be an ...
This single-arm, multicenter Phase II study assessed the efficacy and safety of olverembatinib in combination with the VP (vindesine+prednisone) regimen (OVP) in the first-line treatment of adult ...
Findings from HERTHENA-Lung02 showed that the key secondary endpoint of overall survival did not meet statistical significance.
Dizal announced the completion of patient enrollment for its WU-KONG28 clinical trial: a multinational, randomized phase III ...
Persistent fever without infection could be a hidden sign of kidney cancer, according to experts. Other symptoms may include ...
PE Hub has rounded up six deals going back to early January involving companies in the oncology segment, starting with the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results